NovaBay Pharmaceuticals, Inc. Annual Return On Assets in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
NovaBay Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2014 to 2023.
  • NovaBay Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -182 %, a 99.4% decline year-over-year.
  • NovaBay Pharmaceuticals, Inc. annual Return On Assets for 2023 was -73.1 %, a 46.7% decline from 2022.
  • NovaBay Pharmaceuticals, Inc. annual Return On Assets for 2022 was -49.9 %, a 36.7% decline from 2021.
  • NovaBay Pharmaceuticals, Inc. annual Return On Assets for 2021 was -36.5 %, a 54.5% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -73.1 -23.3 -46.7% Jan 1, 2023 Dec 31, 2023
2022 -49.9 -13.4 -36.7% Jan 1, 2022 Dec 31, 2022
2021 -36.5 +43.7 +54.5% Jan 1, 2021 Dec 31, 2021
2020 -80.2 +4.88 +5.74% Jan 1, 2020 Dec 31, 2020
2019 -85.1 -27.2 -47.1% Jan 1, 2019 Dec 31, 2019
2018 -57.9 +6.68 +10.4% Jan 1, 2018 Dec 31, 2018
2017 -64.5 +59.4 +47.9% Jan 1, 2017 Dec 31, 2017
2016 -124 +128 +50.9% Jan 1, 2016 Dec 31, 2016
2015 -252 -129 -104% Jan 1, 2015 Dec 31, 2015
2014 -123 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.